C. Jacquot

Evaluation of the hemostatic potential including thrombin generation of three different therapeutic pathogen‐reduced plasmas

T. Lecompte, C. Geschier, M. Hacquard, 2012, Vox sanguinis.

Comparison of the Hemostatic Efficacy of Pathogen-Reduced Platelets vs Untreated Platelets in Patients With Thrombocytopenia and Malignant Hematologic Diseases: A Randomized Clinical Trial

E. Deconinck, P. Tiberghien, J. Bay, 2018, JAMA oncology.

Antithrombin III and Heparin Cofactor II in Patients with Chronic Renal Failure Undergoing Regular Hemodialysis

M. Aiach, C. Jacquot, P. Toulon, 1987, Thrombosis and Haemostasis.

Anaphylaxis following the use of a plasma‐derived immunopurified Monoclate‐P®, and the recombinant Recombinate® and Kogenate® factor VIII: a therapeutic challenge

B. Polack, G. Pernod, D. Plantaz, 1999, Haemophilia : the official journal of the World Federation of Hemophilia.